Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Nina Staudacher"'
Autor:
Andrea Katharina Lindner, Gert Schachtner, Gennadi Tulchiner, Nina Staudacher, Fabian Steinkohl, Van Anh Nguyen, Wolfgang Horninger, Renate Pichler
Publikováno v:
Urology Case Reports, Vol 23, Iss , Pp 1-2 (2019)
Nivolumab belongs to the standard treatment options in metastatic renal cell carcinoma. Despite promising responses, a new spectrum of “immune-related” adverse effects has to be managed in daily clinical practice. A 74-year-old patient was treate
Externí odkaz:
https://doaj.org/article/139489dff70349a8a74f2e0f84b27c98
Autor:
Leonhard Gruber, Gennadi Tulchiner, Nina Staudacher, Mona Kafka, Ewald Wöll, Thomas Brunhuber, Wolfgang Horninger, Renate Pichler
Publikováno v:
Transl Androl Urol
A solely retroperitoneal mass in males in combination with elevated serum Alpha-Fetoprotein (AFP) and beta-human choriogonadotropin (β-HCG) levels is highly indicative of a metastatic testicular cancer. Although testicular cancers are rare, they rep
Autor:
Bettina G. Zelger, Andrea Brunner, Friedrich Aigner, Fabian Steinkohl, Martin Thurnher, Andrea Katharina Lindner, Nina Staudacher, Renate Pichler, Wolfgang Horninger, Gennadi Tulchiner, Hanno Ulmer
Publikováno v:
Cancer Immunology, Immunotherapy
Renal cell carcinoma (RCC) is a highly vascularized and immunogenic tumor, being an ideal candidate for checkpoint blockade-based immunotherapy. Accordingly, checkpoint inhibitors have demonstrated clinical efficacy in patients with metastatic RCC (m
Autor:
Andrea Katharina Lindner, Tobias Furlan, Jacob J. Orme, Gennadi Tulchiner, Nina Staudacher, David D’Andrea, Zoran Culig, Renate Pichler
Publikováno v:
Journal of clinical medicine. 11(8)
Platinum-based chemotherapy is the standard of care with concern to first-line systemic therapy for metastatic disease in urothelial cancer (UC). Resistance to chemotherapy despite an initial response is linked with the ability to remove platinum-bas
Autor:
Gennadi Tulchiner, Zoran Culig, Christian Radmayr, Renate Pichler, Josef Fritz, Wolfgang Horninger, Nina Staudacher
Publikováno v:
Cancers
Volume 13
Issue 8
Cancers, Vol 13, Iss 1754, p 1754 (2021)
Volume 13
Issue 8
Cancers, Vol 13, Iss 1754, p 1754 (2021)
Coronavirus-19 (COVID-19)-induced effects on deferred diagnosis and treatment of bladder cancer (BC) patients are currently not clarified. The aim of this study was to evaluate outcomes of the COVID-19 pandemic by considering its effects on tumor sta
Autor:
Renate Pichler, Mona Kafka, Friedrich Aigner, Gennadi Tulchiner, Wolfgang Horninger, Katie Bates, Michael Ladurner, Nina Staudacher
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 2911, p 2911 (2020)
Journal of Clinical Medicine
Volume 9
Issue 9
Journal of Clinical Medicine
Volume 9
Issue 9
Background: This study was conducted in order to analyze factors predicting malignancy in patients undergoing organ-sparing surgery (OSS) for small testicular lesions. Methods: Patients with small (&le
20 mm) marker-negative clinical stage I tes
20 mm) marker-negative clinical stage I tes
Autor:
Herbert Augustin, Josef Fritz, Wolfgang Horninger, Nina Staudacher, Renate Pichler, Karl Hermann Grubmüller, Kilian M. Gust, Maximilian Seles, Shahrokh F. Shariat, Sebastian Graf, Martin Pichler, Lukas Lusuardi, David D'Andrea, Stephan Madersbacher, Andreas P. Berger, Monika Hackl, Gennadi Tulchiner, Wolfgang Loidl, Walter Albrecht
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5377, p 5377 (2021)
Cancers, Vol 13, Iss 5377, p 5377 (2021)
Simple Summary Seasonal variations in cancer diagnosis could already be demonstrated in prostate and breast cancer. The reasons for this observed seasonal pattern are still unclear. The health care system or other determinants such as the protective
Autor:
Nina Staudacher, Manuela Schmidinger, Renate Pichler, Gennadi Tulchiner, Andrea Brunner, Wolfgang Horninger, Zoran Culig, Jacob J. Orme, Martin Thurnher
Publikováno v:
Bju International
The introduction of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of metastatic renal cell carcinoma (mRCC) [1]. The expression of programmed death-ligand 1 (PD-L1) as assessed by immunohistochemistry (IHC) has been extensively
Autor:
Gennadi Tulchiner, Nina Staudacher, Van Anh Nguyen, Renate Pichler, Wolfgang Horninger, Gert Schachtner, Andrea Katharina Lindner, Fabian Steinkohl
Publikováno v:
Urology Case Reports
Urology Case Reports, Vol 23, Iss, Pp 1-2 (2019)
Urology Case Reports, Vol 23, Iss, Pp 1-2 (2019)
Nivolumab belongs to the standard treatment options in metastatic renal cell carcinoma. Despite promising responses, a new spectrum of “immune-related” adverse effects has to be managed in daily clinical practice. A 74-year-old patient was treate
Autor:
Gerald Klinglmair, Andrea Katharina Lindner, Gennadi Tulchiner, Josef Fritz, Renate Pichler, Christoph Reinhold Arnold, Wolfgang Horninger, Isabel Heidegger, Gert Schachtner, Nina Staudacher, Sergej Skvortsov, O. Kavaiou
Publikováno v:
European Urology Supplements. 18:e2112